CAPTRUST Financial Advisors
LABD icon

CAPTRUST Financial Advisors’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

CAPTRUST Financial Advisors’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-420
Closed -$81K – 4710
2021
Q2 		$81K Buy
420
+240
+133% +$53.8K ﹤0.01% 2186
2021
Q1 		$39K Buy
+180
New +$34.9K ﹤0.01% 2590

Other funds holding LABD

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAPTRUST Financial Advisors's LABD Position: Q3 2021 in Review

CAPTRUST Financial Advisors sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q3 2021, closing a stake of 420 shares — an estimated $81K sold.

CAPTRUST Financial Advisors first reported a position in LABD in Q1 2021 and held it in 2 quarters. The position peaked at $81K in Q2 2021. 17 funds tracked by Wall St. Rank hold LABD as of Q3 2021.

  • CAPTRUST Financial Advisors reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q3 2021 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 420 Direxion Daily S&P Biotech Bear 3X ETF shares in Q3 2021, an estimated $81K.
  • CAPTRUST Financial Advisors first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2021 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $81K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.